Diabetes Cure Blog

Research shows that the number of diabetic patients has increased twofold in the last 20 years. The only solution for fighting diabetes is to be conscious about the disease.

The first Seattle-Sweden Childhood Diabetes Awareness Day in Seattle, Washington is being organized by Professor Åke Lernmark who works at the University of Washington and the Consulate General of Sweden in L.A., on 1st April. The symposium will feature presentations by researchers from Sweden and Seattle. Speakers include Professor Carl David Agardh of Malmö’s University [...]

To check the growing cases of Diabetes, New York Mayor Michael R Bloomberg launched the American Diabetes Association’s (ADA) ad campaign “Are You at Risk?”, a nationwide summon to identify millions of Americans who are unaware of this disease.

There was lots of excitement and hope over Phase 2 trial of INGAP. At one time the positive results were coming in even though one of the participants, I personally know, complained of not benefitting from the trial. We thought he could be part of control group. The final result of Phase 2 trial is [...]

The Quigley Corporation has filed an application with the FDA to begin clinical trials of QR-333 for the treatment of diabetic peripheral neuropathy.

Researcher Massimo Trucco at Children’s Hospital of Pittsburgh have observed marked amelioration of diabetes in a mouse model by a novel treatment strategy involving specific modification of the animal’s own dendritic cells, thereby reversing diabetes in animal studies.

Before people develop Type2 Diabetes, they almost always have Pre-Diabetes a condition where blood glucose levels are higher than normal but not high enough to be diagnosed as Diabetes.

High insulin levels and increased resistance to the hormone are found to be associated with a higher risk of pancreatic cancer. A healthy diet and lifestyle may help to reduce the risk of it.

People with Peripheral Artery Disease or PAD (a condition where blood flow to the legs is reduced) and non-insulin dependent type 2 diabetes are more likely to die from heart related ailment.

IGT (Insulin Glucose Tolerance) is a stage prior to the person becoming diabetic. Patients with IGT often will have normal or only minimally elevated HbA1c values but frequently will have other features of metabolic or ‘insulin resistance’ syndrome, explaining the increasing risk of vascular disease.